167 related articles for article (PubMed ID: 28758197)
1. Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.
Kim EJ; Lee JG; Kim JY; Song SH; Joo DJ; Huh KH; Kim MS; Kim BS; Kim YS
Immunology; 2017 Dec; 152(4):628-637. PubMed ID: 28758197
[TBL] [Abstract][Full Text] [Related]
2. Role of Thalidomide on the Expression of OX40, 4-1BB, and GITR in T Cell Subsets.
Kim BS; Kim JY; Kim EJ; Lee JG; Joo DJ; Huh KH; Kim MS; Kim YS
Transplant Proc; 2016 May; 48(4):1270-4. PubMed ID: 27320601
[TBL] [Abstract][Full Text] [Related]
3. Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells.
Kim EJ; Kim JY; Choi HY; Lee H; Lee J; Kim MS; Kim YS; Huh KH; Kim BS
Yonsei Med J; 2021 Feb; 62(2):137-148. PubMed ID: 33527793
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy.
Scott GB; Carter C; Parrish C; Wood PM; Cook G
Cell Immunol; 2015 Sep; 297(1):1-9. PubMed ID: 26051632
[TBL] [Abstract][Full Text] [Related]
5. The Immunomodulating Effects of Thalidomide and Dexamethasone in a Murine Cardiac Allograft Transplantation Model.
Kim SJ; Kim JY; Kim EJ; Lee H; Cho Y; Kim MS; Kim YS; Kim BS; Huh KH
Yonsei Med J; 2022 Feb; 63(2):158-165. PubMed ID: 35083901
[TBL] [Abstract][Full Text] [Related]
6. Immune modulatory effect of thalidomide on T cells.
Kim BS; Kim JY; Lee JG; Cho Y; Huh KH; Kim MS; Kim YS
Transplant Proc; 2015 Apr; 47(3):787-90. PubMed ID: 25891732
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
Kumar P; Bhattacharya P; Prabhakar BS
J Autoimmun; 2018 Dec; 95():77-99. PubMed ID: 30174217
[TBL] [Abstract][Full Text] [Related]
8. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
[TBL] [Abstract][Full Text] [Related]
9. Enhanced activity of Akt in Teff cells from children with lupus nephritis is associated with reduced induction of tumor necrosis factor receptor-associated factor 6 and increased OX40 expression.
Kshirsagar S; Binder E; Riedl M; Wechselberger G; Steichen E; Edelbauer M
Arthritis Rheum; 2013 Nov; 65(11):2996-3006. PubMed ID: 23896866
[TBL] [Abstract][Full Text] [Related]
10. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
11. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
Galustian C; Meyer B; Labarthe MC; Dredge K; Klaschka D; Henry J; Todryk S; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB; Dalgleish AG
Cancer Immunol Immunother; 2009 Jul; 58(7):1033-45. PubMed ID: 19009291
[TBL] [Abstract][Full Text] [Related]
12. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
[TBL] [Abstract][Full Text] [Related]
13. TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.
Hamano R; Huang J; Yoshimura T; Oppenheim JJ; Chen X
Eur J Immunol; 2011 Jul; 41(7):2010-20. PubMed ID: 21491419
[TBL] [Abstract][Full Text] [Related]
14. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.
Baeyens A; Saadoun D; Billiard F; Rouers A; Grégoire S; Zaragoza B; Grinberg-Bleyer Y; Marodon G; Piaggio E; Salomon BL
J Immunol; 2015 Feb; 194(3):999-1010. PubMed ID: 25548233
[TBL] [Abstract][Full Text] [Related]
15. Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.
Kim YH; Shin SM; Choi BK; Oh HS; Kim CH; Lee SJ; Kim KH; Lee DG; Park SH; Kwon BS
J Immunol; 2015 Nov; 195(10):4721-9. PubMed ID: 26423152
[TBL] [Abstract][Full Text] [Related]
16. In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans.
Hougardy JM; Verscheure V; Locht C; Mascart F
Microbes Infect; 2007 Sep; 9(11):1325-32. PubMed ID: 17890131
[TBL] [Abstract][Full Text] [Related]
17. [Effects of glucocorticoids on the expression of GTIR and apoptosis of the CD4(+)CD25(+)CD127(dim/-) T cells in patients with systemic lupus erythematosus].
Pan Y; Li XP; Sun JF; Wang L; Chen Z; Li XM; Tao JH; Qian L; Zhang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):215-20. PubMed ID: 22516990
[TBL] [Abstract][Full Text] [Related]
18. The origin of thymic CD4+CD25+ regulatory T cells and their co-stimulatory requirements are determined after elimination of recirculating peripheral CD4+ cells.
Zhan Y; Bourges D; Dromey JA; Harrison LC; Lew AM
Int Immunol; 2007 Apr; 19(4):455-63. PubMed ID: 17314081
[TBL] [Abstract][Full Text] [Related]
19. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
Metzger TC; Long H; Potluri S; Pertel T; Bailey-Bucktrout SL; Lin JC; Fu T; Sharma P; Allison JP; Feldman RM
Cancer Res; 2016 Jul; 76(13):3684-9. PubMed ID: 27197182
[TBL] [Abstract][Full Text] [Related]
20. Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.
Voo KS; Bover L; Harline ML; Vien LT; Facchinetti V; Arima K; Kwak LW; Liu YJ
J Immunol; 2013 Oct; 191(7):3641-50. PubMed ID: 24014877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]